HEGLN Buys Non-Invasive Urological Diagnostic Technology

HEGLN (Dalian) Pharmaceutical, a China biotech company, paid $2 million (US) to acquire the uroNIRS technology from Urodynamix Technologies Ltd. of Canada. The uroNIRS machines use near-infrared spectroscopy (NIRS) as a non-invasive means of diagnosing urologic conditions. More details... Stock Symbol: (TSX Venture: URO)